Answers are grounded in this paper and cite their sources.
In connection with our studies on antibacterial active compounds in the class of new oxazolidinones against Gram‐positive ( Staphylococcus aureus ) and Gram‐negative ( Escherichia coli ) strains, some molecular modifications were attempted. In this study, molecular modifications of 4‐aminomethyloxazolidin‐2‐ones ( 3a ) to the corresponding 4‐acylaminomethyloxazolidin‐2‐one derivatives ( 3c–d ) and preparations of the represented twin‐drug type molecules ( 10–14 ) were investigated. Some additional 4‐dialkylaminomethyloxazolidin‐2‐ones ( 2 ) were also synthesized. The synthesized compounds were evaluated for antibacterial activity with Gram‐positive ( S. aureus ) and Gram‐negative ( E. coli ) strains.
No takes yet. Share an insight, caveat, or question.
Fujisaki et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: